Tumor environments exhibit fluctuating expressions of ALOX15 across a broad range of tissues: while it is abundantly present in cancerous tissues of the breast, prostate, lung, head and neck, and colorectal cancers, its expression is lost in tumors of the brain, muscle, or germline cells [88]. This evidence concerns the gene ALOX15 and colorectal cancer.